Prolonged Survival

CAR T therapies represent a remarkable blend of cellular therapy, immunotherapy, and gene therapy. They are not merely drugs, but "living" medicines infused into patients. As immunotherapies, they harness the body's immune cells to fight cancer cells. Moreover, they stand as pioneering gene therapies, with genetically engineered lymphocytes targeting and combating the disease.